Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03250988
Collaborator
Allergan (Industry)
60
1
6
10

Study Details

Study Description

Brief Summary

The purpose of this study is to improve spasticity diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral.

Detailed Description

The aim of this study is to improve spasticity (a form of muscle rigidity) diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral. This will be done by assessing the relatedness of comorbid conditions in patients with spasticity. Emphasis will be placed on urinary incontinence, as previous work has suggested a link between the two conditions. An additional aim of this study is to assess health-related quality of life measures in this population. A medical record review will be performed for all consenting participants residing in Tennessee State Veterans' Homes, which is a long-term care facility in Murfreesboro, TN. Participants will also be asked to complete a brief questionnaire assessing their perceived health-related quality of life, physical wellbeing, and mental wellbeing.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Actual Study Start Date :
Jan 30, 2018
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Aug 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Prevalence of comorbid spasticity and urinary incontinence in a long-term care facility [Up to three months after consent is obtained]

    Prevalence of spasticity will be determined by recording the presence/absence of spasticity based on the neurological examination performed on all consenting residents of the long-term care facility. Prevalence of urinary incontinence will be determined by medical record review of all consenting residents of the long-term care facility. The research coordinator will report prevalence of comorbid spasticity and incontinence as a descriptive statistic.

Secondary Outcome Measures

  1. Quality of life in residents of a long-term care facility [Up to three months after consent is obtained]

    Subjects (if able) will be asked to complete the EQ-5D-5L questionnaire assessing their perceived health-related quality of life. If the subject is unable to complete the EQ-5D-5L questionnaire, the legal medical decision maker or a relative or friend will be asked to complete the EQ-5D-5L proxy to patient questionnaire, assessing the proxy's view of how the subject perceives their health-related quality of life.

  2. Physical and mental well-being in residents of a long-term care facility [Up to three months after consent is obtained]

    Subjects (if able) will be asked to complete the EQ-5D-5L questionnaire assessing their physical and mental well-being. If the subject is unable to complete the EQ-5D-5L questionnaire, the legal medical decision maker or a relative or friend will be asked to complete the EQ-5D-5L proxy to patient questionnaire, assessing the proxy's view of how the subject perceives their physical and mental well-being.

  3. Perceived disability in residents of a long-term care facility [Up to three months after consent is obtained]

    Subjects (if able) will be asked to complete the EQ-5D-5L questionnaire assessing their perceived disability. If the subject is unable to complete the EQ-5D-5L questionnaire, the legal medical decision maker or a relative or friend will be asked to complete the EQ-5D-5L proxy to patient questionnaire, assessing the proxy's view of how the subject perceives their disability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female subjects of any race, aged 18 and above

  • Resident of the selected long-term care facility

  • The subject, or if appropriate their medical decision maker, is willing and able to provide written informed consent.

Exclusion Criteria:
  • Subjects for whom participation in the study may cause medical harm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tennessee State Veterans' Homes Murfreesboro Tennessee United States 37130

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • Allergan

Investigators

  • Principal Investigator: David Charles, M.D., Vanderbilt University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David Charles, Professor and Vice-Chairman of Neurology, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT03250988
Other Study ID Numbers:
  • 170963
First Posted:
Aug 16, 2017
Last Update Posted:
Oct 9, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2018